Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy-Reference-Cited by-同舟云学术

Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy

Published:2020-01-13 Issue:7 Volume:55 Page:1220-1228
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Fuji Shigeo^ORCID,Nagler Arnon,Mohty Mohamad,Savani Bipin^ORCID,Shouval Roni

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0784-x.pdf

Reference54 articles.

1. Thiruvenkatachari B. Randomized controlled trials: the technique and challenges. J Indian Orthodontic Soc. 2019;49:42–47.

2. Gale RP, Zhang MJ. Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky. Bone Marrow Transplant. 2020;55:1–3.

3. Kim H, Goodall S, Liew D. Health technology assessment challenges in oncology: 20 years of value in health. Value Health. 2019;22:593–600.

4. Bullement A, Cranmer HL, Shields GE. A review of recent decision-analytic models used to evaluate the economic value of cancer treatments. Appl Health Econ Health Policy. 2019;17:771–80.

5. Kadom N, Itri JN, Trofimova A, Otero HJ, Horny M. Cost-effectiveness analysis: an overview of key concepts, recommendations, controversies, and pitfalls. Acad Radio. 2019;26:534–41.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of stress-induced hematopoiesis;Current Opinion in Hematology;2020-05-06